Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Market Cap
$218.42M
Interest Coverage Ratio
N/A
TTM Avg
39.15x
3Y Avg
39.15x
5Y Avg
39.15x
Market Cap
$228.41M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$206.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.56M
Interest Coverage Ratio
-3.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.45M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$202.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.89M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$244.25M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $220.94M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $218.42M | N/A | 39.15x | 39.15x | 39.15x |
| Keros Therapeutics, Inc. (KROS)vs › | $228.41M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | -3.60x | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | -133.11x | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | -1.08x | 0.39x | 0.39x | 0.20x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 0.97x | 0.97x | 0.97x | 0.97x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.56M | 0.57x | 0.57x | 0.57x | 0.57x |
Interest Coverage
N/A
Debt/Equity
N/A
Current Ratio
5.26
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
